Page 41 - ESHRE2019

Refs
• Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries – compilation of 20 years of multicenter experience, Rodriguez-Wallberg et al, Acta OGS, 95 (2016) 1015–1026
• Oocyte and ovariantissue cryopreservation in European countries:statutory background, practice, storage and use, The ESHRE Working Group on Oocyte Cryopreservation in Europe, Shenfield et al, HR open, 1–9, 2017
• FP for medical reasons in girls and women:BFS policy and practice guidelines, Yasmin et al (2018), Human Fer, 21(1): 3-26
• How can we improve oncofertility care for patients? A systematic scoping review of current international practice and models of care, Anazodo et al, Human Reproduction Update, Vol.25, No.2 pp. 159–179, 2019
• Setting up a fertility preservation programme, Stern and Agresta, Best Practice & Research Clinical Obstetrics and Gynaecology 55 (2019) 67e78
Refs
•
•
•
The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), De Geyter et al (2018), ART in Europe, 2014: results generated from European registries by ESHRE, Human Reproduction,33 (9): 1586–1601.
Rapport d’activité annuel d’AMP – Activité 2016, ABM, Agence de la biomédecine https://www.agence-biomedecine.fr/ pub 2019
Gook and Edgar, Cryopreservation of female reproductive potential, Best Practice & Research Clinical Obstetrics and Gynaecology 55 (2019) 23e36
• Creating a global community of Prartice for Oncofertility, Woodruff et al (2016),
JGO(2), 2
36
PRECONGRESS COURSE 05 I VIENNA, AUSTRIA – 23 JUNE 2019 39